Related Experiment Video
Updated: Aug 5, 2026
Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
Quitline Counsellors' Experiences With Vaping and Nicotine Replacement Therapy for Smoking Cessation in Australian
Jane L Rich1, Catherine J Segan2,3, Joshua Trigg4
1College of Health, Medicine and Wellbeing, University of Newcastle, Newcastle, Australia.
Introduction:
In Australia, people undergoing inpatient treatment for alcohol and other drug (AOD) use disorders have a high prevalence of tobacco smoking. Smoking cessation support is routinely offered to clients within inpatient withdrawal settings, but continued support post-discharge typically is not. The current study qualitatively explores attitudes and experiences of Quitline counsellors involved in a two-armed trial for clients with provision of 12 weeks of nicotine vaping products (NVPs) or combination nicotine replacement therapy (cNRT).
Methods:
Two focus groups of Quitline counsellors (six per group) explored how they felt about training received, their beliefs and attitudes about NVPs and cNRT for smoking cessation for AOD-use population and their wider experience supporting AOD clients. Data were inductively coded.
Results:
Six themes were identified: (i) Counsellor Readiness and Professional Adaptation to Emerging Cessation Tools; (ii) Addressing Complexity: Behavioural Support in Multi-Substance Recovery Contexts; (iii) Client Preferences and Product Engagement in Cessation Support; (iv) Continuity of Care: Bridging Residential Treatment and Community Support; (v) Enablers of Quality Practice: Training, Resources and Organisational Support; and (vi) Service Integration and Boundary Management in Specialised Populations.
Discussion And Conclusions:
The agility of Quitline services models their potential to partner with clinical research teams and AOD services to build the evidence-base around the effectiveness of reduced-harm nicotine products for people with complex needs. The Victorian Quitline partnership with the NEAT trial produced a comprehensive service model assisting people seeking AOD treatment to quit smoking that highlights the workforce as a modifiable factor by involving staff in evidence-building adaptability.
Related Concept Videos
01:29Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
01:17Drug Dependence
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
01:27CNS Depressants: Alcohol and Nicotine
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:24Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...